1. The Telomerase-Derived Anticancer Peptide Vaccine GV1001 as an Extracellular Heat Shock Protein-Mediated Cell-Penetrating Peptide
    Hong Kim et al, 2016, IJMS CrossRef
  2. Peptide-Based Treatment: A Promising Cancer Therapy
    Yu-Feng Xiao et al, 2015, Journal of Immunology Research CrossRef
  3. Therapeutic Targeting of Telomerase
    Kathrin Jäger et al, 2016, Genes CrossRef
  4. Trial Watch: Peptide-based anticancer vaccines
    Jonathan Pol et al, 2015, OncoImmunology CrossRef
  5. Vaccines targeting helper T cells for cancer immunotherapy
    Marit Melssen et al, 2017, Current Opinion in Immunology CrossRef
  6. Telomerase based anticancer immunotherapy and vaccines approaches
    Chahal Kailashiya et al, 2017, Vaccine CrossRef
  7. null
    Reshma J. Nevagi et al, 2018 CrossRef
  8. Emerging trends in the immunotherapy of pancreatic cancer
    Kasturi Banerjee et al, 2017, Cancer Letters CrossRef
  9. Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potential
    Gregory T. Wurz et al, 2016, Ther Adv Med Oncol CrossRef
  10. Telomerase activity: An attractive target for cancer therapeutics
    Lucia Picariello, 2014, WJP CrossRef
  11. GV1001 Induces Apoptosis by Reducing Angiogenesis in Renal Cell Carcinoma Cells Both In Vitro and In Vivo
    Ga Eun Kim et al, 2017, Urology CrossRef
  12. Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners
    Paola Cappello et al, 2018, Cancers CrossRef
  13. Membrane Active Peptides and Their Biophysical Characterization
    Fatma Gizem Avci et al, 2018, Biomolecules CrossRef
  14. Optimized Gemcitabine Therapy in Combination with E7 Peptide Immunization Elicits Tumor Cure by Preventing Ag-Specific CTL Inhibition in Animals with Large Established Tumors
    Ho-Young Jang et al, 2018, DNA and Cell Biology CrossRef
  15. The Anti-inflammatory Effect of GV1001 Mediated by the Downregulation of ENO1-induced Pro-inflammatory Cytokine Production
    Jiyea Choi et al, 2015, Immune Netw CrossRef
  16. Small molecule tyrosine kinase inhibitors and pancreatic cancer—Trials and troubles
    Bhaskar Venkata Kameswara Subrahmanya Lakkakula et al, 2018, Seminars in Cancer Biology CrossRef
  17. Telomerase-Targeted Cancer Immunotherapy.
    Eishiro Mizukoshi et al, 2019, Int J Mol Sci CrossRef
  18. A second chance for telomerase reverse transcriptase in anticancer immunotherapy.
    Maurizio Zanetti, 2017, Nat Rev Clin Oncol CrossRef
  19. Raising the bar in anticancer therapy: recent advances in, and perspectives on, telomerase inhibitors
    A. Prasanth Saraswati et al, 2019, Drug Discovery Today CrossRef
  20. A telomerase-derived peptide regulates reactive oxygen species and hepatitis C virus RNA replication in HCV-infected cells via heat shock protein 90
    Seoung-Ae Lee et al, 2016, Biochemical and Biophysical Research Communications CrossRef
  21. Reduction of ischaemia–reperfusion injury in a rat lung transplantation model by low-concentration GV1001
    Ji-Eun Chang et al, 2016, Eur J Cardiothorac Surg CrossRef
  22. Telomere maintenance in soft tissue sarcomas
    Nicholas Eastley et al, 2017, J Clin Pathol CrossRef
  23. null
    Fangjun Chen et al, 2017 CrossRef
  24. A Telomerase-derived Peptide Vaccine Inhibits Laser-induced Choroidal Neovascularization in a Rat Model
    Eun Kyoung Lee et al, 2019, Translational Research CrossRef
  25. null
    Argha Mario Mallick et al, 2019 CrossRef
  26. Active immunotherapy of cancer: An overview of therapeutic vaccines
    Brankica Filipić et al, 2019, Arhiv za farmaciju CrossRef
  27. Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects
    Ke-Yu Li et al, 2020, Chronic Diseases and Translational Medicine CrossRef
  28. Telomerase-based Cancer Therapeutics: A Review on their Clinical Trials
    Nicola Relitti et al, 2020, CTMC CrossRef
  29. Potential Telomere-Related Pharmacological Targets
    Joseph Berei et al, 2020, CTMC CrossRef
  30. Immunotherapy for patients with advanced pancreatic carcinoma: a promising treatment
    Bin Zhang et al, 2017, Oncotarget CrossRef
  31. Telomerase and CD4 T Cell Immunity in Cancer
    Magalie Dosset et al, 2020, Cancers CrossRef
  32. Design, synthesis and SARs of novel telomerase inhibitors based on BIBR1532
    Chao Liu et al, 2020, Bioorganic Chemistry CrossRef
  33. Role of Telomeres and Telomeric Proteins in Human Malignancies and Their Therapeutic Potential
    Stina George Fernandes et al, 2020, Cancers CrossRef
  34. Anti-Cancer Immunotherapies Targeting Telomerase
    Simone Negrini et al, 2020, Cancers CrossRef
  35. Advances in Targeted Therapy and Immunotherapy for Pancreatic Cancer
    Xiaoxiao Liu et al, 2021, Advanced Biology CrossRef
  36. The Role of Telomerase and Viruses Interaction in Cancer Development, and Telomerase-Dependent Therapeutic Approaches
    Ali Salimi-Jeda et al, 2021, Cancer Treatment and Research Communications CrossRef
  37. Telomeres and Cancer.
    Hueng-Chuen Fan et al, 2021, Life (Basel) CrossRef
  38. Harnessing Antitumor CD4+ T Cells for Cancer Immunotherapy
    Myriam Ben Khelil et al, 2022, Cancers CrossRef
  39. Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies
    Jixuan Gao et al, 2022, Nat Rev Cancer CrossRef
  40. Emerging concepts in designing next-generation multifunctional nanomedicine for cancer treatment
    Kasturee Chakraborty et al, 2022 CrossRef
  41. Potential association factors for developing effective peptide-based cancer vaccines
    Chongming Jiang et al, 2022, Front. Immunol. CrossRef
  42. The role of cell-penetrating peptides in potential anti-cancer therapy.
    Meiling Zhou et al, 2022, Clin Transl Med CrossRef
  43. Identification of Cancer Cells in the Human Body by Anti-Telomerase Peptide Antibody: Towards the Isolation of Circulating Tumor Cells
    Olga Karpov et al, 2022, IJMS CrossRef